Abstract
Pyruvate is oxidized to acetyl‐CoA by pyruvate dehydrogenase which is localized in the mitochondrial matrix. The mitochondrial pyruvate carrier (MPC) is composed of SLC54 family members (MPC1 and MPC2) [1, 5], which form functional hetero-dimers [9, 8]. The MPC is expressed in the inner mitochondrial membrane and involved in the import of pyruvate into mitochondria [1, 5]. Ubiquitous disruption of either MPC1 or MPC2 expression results in embryonic lethality [11, 12]. Clinically relevant concentrations of the insulin sensitizers, thiazolidinediones, inhibit the MPC [3]. Other clinically relevant inhibitors of the MPC complex are lonidamine [7, 8], quinolone antibacterials [6], entacapone and nitrofurantoin [8].
Original language | English |
---|---|
Number of pages | 2 |
Journal | IUPHAR/BPS Guide to Pharmacology CITE |
Volume | 2023 |
Issue number | 1 |
DOIs | |
Publication status | Published - 26 Apr 2023 |
Keywords
- pyruvate
- pyruvate dehydrogenase
- insulin sensitizers
- mitochondrial pyruvate carrier